Evidence map›Paper›PMID 38362584›Full record

ArticleJournal of cardiology cases2024

Recovery of cardiac metabolic function after high-dose prednisolone in a patient with inflammatory myopathy associated with anti-mitochondrial antibody.

Rikuya Tanaka, Shingo Ota, Mana Taniguchi, Jinsoo Koh, Hidefumi Ito, Shinichi Murata, Atsushi Tanaka

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Journal of cardiology cases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Rikuya TanakaDepartment of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.
Shingo OtaDepartment of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.
Mana TaniguchiDepartment of Neurology, Wakayama Medical University, Wakayama, Japan.
Jinsoo KohDepartment of Neurology, Wakayama Medical University, Wakayama, Japan.
Hidefumi ItoDepartment of Neurology, Wakayama Medical University, Wakayama, Japan.
Shinichi MurataDepartment of Human Pathology and Diagnostic Pathology, Wakayama Medical University, Wakayama, Japan.
Atsushi TanakaDepartment of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.
Wakayama Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myocardial complications in the setting of inflammatory myopathy associated with anti-mitochondrial antibody (AMA) cause various cardiovascular complications. A 64-year-old Japanese man was diagnosed with inflammatory myopathy associated with AMA, and three years after diagnosis, the patient was referred to our hospital with leg edema and dyspnea on exertion. Right ventricular endomyocardial biopsy showed no disease-specific findings, with neither inflammatory cell infiltration nor non-caseating epithelioid cell granuloma, and only mild fibrosis; therefore, we finally diagnosed this patient with cardiac involvement in inflammatory myopathy associated with AMA. Learning objective: Although the definitive diagnosis of cardiac involvement in inflammatory myopathy associated with anti-mitochondrial antibody is difficult because of the rarity of this condition and no disease-specific findings in imaging and histology, physicians should consider this in patients with cardiac dysfunction and muscle weakness.

Indexed as

123I-β-methyl-p-iodophenyl-pentadecanoic acid cardiac scintigraphyAnti-mitochondrial antibody-associated cardiomyopathyPrednisolone

Identifiers

PMID38362584
PMCPMC10865124
OpenAlexW4388593062

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.